Profile: Genzyme Corporation is a global biotechnology company. We focus on rare inherited disorders, kidney disease, orthopedics, cancer, transplant and immune disease. We offer renagel® which is a unique calcium-free, metal-free phosphate binder. It is indicated for the control of serum phosphorus in patients with chronic kidney disease on hemodialysis. Our product hectorol® (doxercalciferol) is a vitamin D2 analog indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease Stages 3, 4 (capsules) and 5 (capsules and injection). It provides significant PTH reductions with minimal impact on calcium and phosphorus levels. Epicel® is a permanent skin replacement product for patients with life-threatening burns.